drugset / Trial / NCT07571928

A Novel Aromatase Inhibitor, Leflutrozole, for Treatment of Non-Obstructive Azoospermia

NCT07571928 ↗

Phase 1/2 Not yet recruiting 15 enrolled Martin Blomberg Jensen ReproNovo Aps · collab
NaSingle-groupOpen-labelTreatment

Summary

This clinical interventional study aims to assess whether treatment with with leflutrozole can improve sperm production in infertile men with non-obstructive azoospermia selected by serum anti-mullerian hormone (AMH) or Inhibin B as a positive predictive biomarker.

Timeline

Start
2026-05-01
Primary completion
2027-05-31
Completion
2027-08-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Leflutrozole Unknown 0.3 mg Oral

Indications